Neuro-Ophthalmology News

The FDA granted priority review to idebenone for the treatment of Leber hereditary optic neuropathy, according to a press release from Chiesi Global Rare Diseases.

BALTIMORE — A virtual reality eye tracking device may be a reliable tool to assist clinicians in determining the cognitive status of athletes who are recovering from mild traumatic brain injury, according to a poster presentation.

Neurodegeneration in multiple sclerosis can be monitored via OCT of inner retinal layers in the macular region, according to a study published in Frontiers in Neurology.

Outcomes in acute optic neuritis tend to be worse at 6 months for men, patients who are older and those with poorer high-contrast visual acuity at baseline, according to an analysis published in Ophthalmology.

LAS VEGAS — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, discusses the phase 2 ACUITY trial investigating privosegtor for neuroprotection in patients with optic neuritis.

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January 2020. Then, COVID hit.

Spearheaded by the World Federation of Neurology, World Brain Day on July 22 will celebrate the theme of “Brain Health for All Ages” and prevention of neurological disorders.

A plant-based but not fully vegetarian diet could boost the health of retinal ganglion cells, potentially mitigating early neurodegeneration visible on OCT, according to a study published in The Journal of Nutrition, Health and Aging.

An oral therapy to treat Wolfram syndrome significantly improved pancreatic functions and induced improvement in symptoms at 24 and 48 weeks for most participants in a phase 2 trial.